Remove 2024 Remove Clinic Remove Diabetes Remove Relationship
article thumbnail

The Physicians Foundation Announces New Recipient in Leadership Award Program, Recognized for Addressing Drivers of Health

The Physicians Foundation

is honored for his transformative work, connecting patients with primary care and critical health resources BOSTON, August 15, 2024 – The Physicians Foundation is proud to announce Jubril Oyeyemi, M.D., In July 2024, The Physicians Foundation also honored E. Jubril Oyeyemi, M.D., president of The Physicians Foundation.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 15:32 Could do this in clinical practice.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

Widera and Smith have no relationships to disclose. Guests George Kuchel & Alison Huang have no relationships to disclose. ABIM MOC credit will be offered to subscribers in November, 2024. George 03:01 So I would say that as many clinical issues in older adults, we need to think about them in two ways.

IT 120
article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.

article thumbnail

Substance Use Disorder in Aging and Serious Illness: A Podcast with Katie Fitzgerald Jones, Jessica Merlin, Devon Check

GeriPal

In particular, we talk about Katie’s and Jesica’s paper in NEJM titled “ Juggling Two Full-Time Jobs — Methadone Clinic Engagement and Cancer Care ,” which described the difficulty in managing cancer pain and methadone for opioid use disorder. Panelists Katie Fitzgerald Jones and Jessica Merlin have no relationships to disclose.

Illness 136
article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

He died in 2024. I, for example, had one patient, I remember during my fellowship, I was in geriatrics clinic and had a very well read patient who came in and was reading a New York Times article, I think in the well section at one point. Alex 16:45 That really rings true with my clinical experience.